Altogether, our findings suggest that gastrin may exert both direct and indirect effects on melanoma cells by enhancing their migration and invasion capabilities, possibly by altering the balance towards the dominance of secreted proteases, e.g., MMP-2, against protease inhibitors, e.g., TIMP-3. Here, MMP2 is linked to melanoma.